# FDA recall D-0130-2019

> **RXQ Compounding LLC** · Class II · drug recall initiated 2018-09-25.

## Product

Lidocaine 1% + Epinephrine 1:100,000 (MDV) INJ SOL, 50 mL per glass vial, Rx only, 340 West State Street, Unit 9, Athens, OH 45701.  NDC  7073197450

## Reason for recall

Subpotent drug: During testing of the retention sample, the firm discovered that the product was sub-potent.

## Distribution

U.S.A. nationwide

## Key facts

- **Recall number:** D-0130-2019
- **Recalling firm:** RXQ Compounding LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2018-09-25
- **Report date:** 2018-10-31
- **Termination date:** 2022-10-18

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Athens, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0130-2019

## Citation

> AI Analytics. FDA recall D-0130-2019. Retrieved 2026-07-08 from https://api.ai-analytics.org/recall/D-0130-2019. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*